Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonarteritic Anterior Ischemic Optic Neuropathy”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableStudy completedNCT01131104
What this trial is testing

Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Eli Lilly and Company 345
Large-scale testing (Phase 3)Ended earlyNCT02341560
What this trial is testing

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non Arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 732
Not applicableStudy completedNCT07330713
What this trial is testing

Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Uludag University 31
Post-approval studies (Phase 4)Study completedNCT01975324
What this trial is testing

A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Non Arteritic Ischemic Optic Neuropathy
Neuro-Ophthalmologic Associates, PC 20
Large-scale testing (Phase 3)UnknownNCT02329288
What this trial is testing

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION

Who this might be right for
Triamcinolone AcetonideOptic Neuropathy, Ischemic
Second Military Medical University 60
Testing effectiveness (Phase 2)UnknownNCT01330524
What this trial is testing

Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo

Who this might be right for
Acute Nonarteritic Anterior Ischemic Optic Neuropathy
Shahid Beheshti University of Medical Sciences 16
Not applicableLooking for participantsNCT06748703
What this trial is testing

Optic Nerve Injury in Obstructive Sleep Apnea Patients

Who this might be right for
Obstructive Sleep Apnea (OSA)Ischemic Optic Neuropathy/Optic Nerve Stroke
Nanjing Medical University 80
Testing effectiveness (Phase 2)Ended earlyNCT03547206
What this trial is testing

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Regenera Pharma Ltd 165
Post-approval studies (Phase 4)Study completedNCT00432393
What this trial is testing

Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
Shahid Beheshti University of Medical Sciences
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Early research (Phase 1)Study completedNCT00561834
What this trial is testing

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy

Who this might be right for
Nonarteritic Anterior Ischemic Optic Neuropathy
University of Colorado, Denver 2